AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36253280 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballistic resistance training
Number of subjects: 144
Study 36253280 — intervention group
Group type: COMPARATOR
Intervention: Non-ballistic exercise rehabilitation
Number of subjects: 144
Study 35176099 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) in dorsal decubitus position with lower limbs raised
Number of subjects: 37
Study 35176099 — intervention group
Group type: COMPARATOR
Intervention: Control (dorsal decubitus position with lower limbs raised without NMES)
Number of subjects: 37
Study 33159002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (20 to 25 sessions of 45 minutes over 5 to 7 weeks)
Number of subjects: 226
Study 33159002 — intervention group
Group type: COMPARATOR
Intervention: Usual teaching
Number of subjects: 226
Study 33159002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training
Number of subjects: 226
Study 36280541 — intervention group
Group type: EXPERIMENTAL
Intervention: 360° virtual counselling environment (360°VCE)
Number of subjects: 86
Study 36280541 — intervention group
Group type: COMPARATOR
Intervention: Routine standard of care counselling
Number of subjects: 86
Study 33385299 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin 400 mg twice daily for 6 months
Number of subjects: 200
Study 33385299 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rifaximin)
Number of subjects: 200
Study 32218417 — intervention group
Group type: EXPERIMENTAL
Intervention: Boric highly mineralized bicarbonate sodium water
Number of subjects: 90
Study 32218417 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly mineralized sulfate-bicarbonate sodium-magnesium water
Number of subjects: 90
Study 32218417 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment complex (dietary and proton pump inhibitor drugs)
Number of subjects: 90
Study 35920065 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets
Number of subjects: 0
Study 35920065 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 0
Study 32326256 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitions 3-4
Number of subjects: 22
Study 32326256 — intervention group
Group type: EXPERIMENTAL
Intervention: All competitions except 2-4
Number of subjects: 22
Study 32326256 — intervention group
Group type: EXPERIMENTAL
Intervention: All competitions
Number of subjects: 22
Study 615245085 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH) intralesional injection (0.58 mg/injection, up to eight injections)
Number of subjects: 189
Study 615245085 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH) intralesional injection
Number of subjects: 189
Study 615245085 — intervention group
Group type: EXPERIMENTAL
Intervention: CCH treatment of male partners
Number of subjects: 189
Study 36493800 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual information delivery
Number of subjects: 90
Study 36493800 — intervention group
Group type: COMPARATOR
Intervention: Verbal information delivery
Number of subjects: 90
Study 36493800 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (audiovisual and verbal)
Number of subjects: 90
Study 33752420 — intervention group
Group type: EXPERIMENTAL
Intervention: Microlecture teaching method
Number of subjects: 84
Study 33752420 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching method (control group)
Number of subjects: 84
Study 32331460 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback Training (BT)
Number of subjects: 159
Study 32331460 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-Delivered Biofeedback Training (SDBT)
Number of subjects: 159
Study 32331460 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 159
Study 36012033 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG rehabilitation robot training
Number of subjects: 0
Study 36012033 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation (Control Group)
Number of subjects: 0
Study 33036660 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI for prostate cancer screening
Number of subjects: 100
Study 36104805 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication intervention between clinical pharmacists and physicians
Number of subjects: 367
Study 36104805 — intervention group
Group type: COMPARATOR
Intervention: Control group (no communication intervention)
Number of subjects: 367
Study 34116919 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise hot water immersion (HWI)
Number of subjects: 27
Study 34116919 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-heat-acclimation (EHA)
Number of subjects: 27
Study 34116919 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral exercise (TNE)
Number of subjects: 27
Study 32805428 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-containing tear supplement (Systane Complete)
Number of subjects: 28
Study 32805428 — intervention group
Group type: COMPARATOR
Intervention: Non-lipid containing eye drop (Systane Ultra)
Number of subjects: 28
Study 32673222 — intervention group
Group type: EXPERIMENTAL
Intervention: ITEC-CHF (telemonitoring program)
Number of subjects: 184
Study 34700598 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with ISBT boost (initial dose 50Gy with IMRT followed by 24.5Gy dose in 12 fractions)
Number of subjects: 70
Study 34700598 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with ISBT boost
Number of subjects: 70
Study 34700598 — intervention group
Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 70
Study 32130284 — intervention group
Group type: EXPERIMENTAL
Intervention: Anorganic xenograft added at the time of flapless, one-stage placement of a sloped-platform implant
Number of subjects: 0
Study 32130284 — intervention group
Group type: COMPARATOR
Intervention: No graft
Number of subjects: 0
Study 32130284 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (graft and no graft)
Number of subjects: 0
Study 35045101 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety promotion intervention (8 sessions)
Number of subjects: 91
Study 33453095 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical formulation (TF) - Product A
Number of subjects: 100
Study 33453095 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Product B)
Number of subjects: 100
Study 34986381 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab and left-sided RT (1270 patients)
Number of subjects: 3321
Study 34986381 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab and right-sided RT (1271 patients)
Number of subjects: 3321
Study 34986381 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab with no RT (780 patients)
Number of subjects: 3321
Study 33972256 — intervention group
Group type: EXPERIMENTAL
Intervention: Etesevimab (2.5 to 50 mg/kg)
Number of subjects: 40
Study 33972256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32852530 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod, 0.5 mg
Number of subjects: 1064
Study 32852530 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod, 0.25 mg
Number of subjects: 1064
Study 32852530 — intervention group
Group type: COMPARATOR
Intervention: Glatiramer acetate, 20 mg
Number of subjects: 1064
Study 35313321 — intervention group
Group type: EXPERIMENTAL
Intervention: Diprospan group (0.5% ropivacaine plus Diprospan)
Number of subjects: 96
Study 35313321 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.5% ropivacaine alone)
Number of subjects: 96
Study 32473673 — intervention group
Group type: EXPERIMENTAL
Intervention: elexacaftor plus tezacaftor plus ivacaftor combination regimen
Number of subjects: 0
Study 32473673 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36121560 — intervention group
Group type: EXPERIMENTAL
Intervention: Diary-supported (paper group; n=49)
Number of subjects: 148
Study 36121560 — intervention group
Group type: EXPERIMENTAL
Intervention: App-supported (app group; n=49)
Number of subjects: 148
Study 36121560 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-supported (therapist group; n=50)
Number of subjects: 148
Study 33591125 — intervention group
Group type: EXPERIMENTAL
Intervention: Subacromial hyaluronate injection (2 mL, 20 mg, hyaluronate 1% (500 to 700 kDa))
Number of subjects: 51
Study 33591125 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy (PT), three sessions per week for 12 weeks (totaling 36 sessions including rotator cuff activation exercises)
Number of subjects: 51
Study 33211739 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated packaging
Number of subjects: 10
Study 33211739 — intervention group
Group type: COMPARATOR
Intervention: Ambient temperature without coated packaging
Number of subjects: 10
Study 33211739 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated packaging at 10°C
Number of subjects: 10
Study 33211739 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated packaging at ambient temperature
Number of subjects: 10
Study 35437111 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azacitidine (CC‐486)
Number of subjects: 0
Study 35437111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32217152 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 53
Study 32217152 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine samples on weekends
Number of subjects: 53
Study 32217152 — intervention group
Group type: EXPERIMENTAL
Intervention: Stool samples during weekdays
Number of subjects: 53
Study 32217152 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of week 1 vs week 4 urine samples
Number of subjects: 53
Study 32217152 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with symptoms
Number of subjects: 53
Study 32217152 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with blood samples
Number of subjects: 53
Study 32293670 — intervention group
Group type: EXPERIMENTAL
Intervention: Social marketing strategies for recruitment (emails, flyers/posters, other sources, multiple sources)
Number of subjects: 460
Study 32293670 — intervention group
Group type: EXPERIMENTAL
Intervention: Flyers/posters
Number of subjects: 460
Study 32293670 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple sources
Number of subjects: 460
Study 32293670 — intervention group
Group type: EXPERIMENTAL
Intervention: Email
Number of subjects: 460
Study 32964829 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 0
Study 32964829 — intervention group
Group type: COMPARATOR
Intervention: MAD
Number of subjects: 0
Study 32964829 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study 33560633 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist actigraphy for sleep efficiency (SE) and total sleep time (TST)
Number of subjects: 31
Study 33560633 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist actigraphy for daytime activity ratio (DAR)
Number of subjects: 31
Study 33560633 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist actigraphy for hourly activity counts
Number of subjects: 31
Study 35961599 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 174
Study 35961599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 33682640 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 168
Study 33682640 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 168
Study 33682640 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 168
Study 33682640 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 168
Study 32623343 — intervention group
Group type: EXPERIMENTAL
Intervention: Sushi roll technique
Number of subjects: 60
Study 32623343 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 60
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate intake (% of energy/d)
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (n-3 PUFAs) intake (g/d)
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavones intake (mg/d)
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake (mg/d)
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline intake (mg/d)
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrates intake among rs738409 G-allele carriers
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFAs intake among rs738409 G-allele carriers
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavones intake among rs738409 G-allele carriers
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake among rs738409 G-allele carriers
Number of subjects: 452
Study 33306506 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline intake among rs738409 G-allele carriers
Number of subjects: 452
Study 34415010 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warning label exposure
Number of subjects: 229
Study 32914563 — intervention group
Group type: EXPERIMENTAL
Intervention: Phaco chop technique
Number of subjects: 66
Study 32914563 — intervention group
Group type: COMPARATOR
Intervention: Drill-and-crack technique
Number of subjects: 66
Study 32881797 — intervention group
Group type: EXPERIMENTAL
Intervention: Collective Advocacy (CA)
Number of subjects: 752
Study 32881797 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Intervention (GI)
Number of subjects: 752
Study 32881797 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Counselling (IC)
Number of subjects: 752
Study 32881797 — intervention group
Group type: EXPERIMENTAL
Intervention: CA + IC + GI sequence
Number of subjects: 752
Study 32881797 — intervention group
Group type: EXPERIMENTAL
Intervention: GI + CA + IC sequence
Number of subjects: 752
Study 35298778 — intervention group
Group type: EXPERIMENTAL
Intervention: DR-BNI intervention
Number of subjects: 0
Study 35298778 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34216139 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Frequency Transcranial Magnetic Stimulation (HF-TMS), 2-week intervention (five 20-minute sessions/week)
Number of subjects: 49
Study 34216139 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Exercise (PE), 8-week low-intensity program (two 60-minute sessions/week)
Number of subjects: 49
Study 34216139 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG), no intervention
Number of subjects: 49
Study 32528665 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message arm
Number of subjects: 200
Study 32528665 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control) arm
Number of subjects: 200
Study 35739371 — intervention group
Group type: COMPARATOR
Intervention: Video lecture
Number of subjects: 24
Study 35739371 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-training (video lecture + self-performed FOCUS)
Number of subjects: 24
Study 35739371 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (self-learning followed by telepresence instruction)
Number of subjects: 24
Study 34130360 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-power (MP) laser device (50 W) at 39.6 W (2.2 J/18 Hz)
Number of subjects: 120
Study 34130360 — intervention group
Group type: COMPARATOR
Intervention: High-power (HP) laser device (100 W) at 42 W (1.2 J/35 Hz)
Number of subjects: 120
Study 36066447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal HD-tDCS targeting the ACC
Number of subjects: 66
Study 36066447 — intervention group
Group type: COMPARATOR
Intervention: Anodal HD-tDCS targeting the ACC
Number of subjects: 66
Study 36066447 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 66
Study 33030020 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1:1000 epinephrine
Number of subjects: 19
Study 33030020 — intervention group
Group type: COMPARATOR
Intervention: Topical 1:10 000 epinephrine
Number of subjects: 19
Study 35187992 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentive (∼$10 USD)
Number of subjects: 215
Study 35187992 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 215
Study 34624930 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Ankle Replacement (TAR)
Number of subjects: 19
Study 34624930 — intervention group
Group type: COMPARATOR
Intervention: Ankle Fusion (AF)
Number of subjects: 19
Study 32703593 — intervention group
Group type: EXPERIMENTAL
Intervention: TiNO-coated stent
Number of subjects: 1491
Study 32703593 — intervention group
Group type: COMPARATOR
Intervention: EES
Number of subjects: 1491
Study 35123476 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace strengthening exercise program
Number of subjects: 166
Study 35123476 — intervention group
Group type: COMPARATOR
Intervention: Control group (ergonomic guidance only)
Number of subjects: 166
Study 34014690 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 34014690 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated briefer versions of each instrument (self-efficacy, coping strategies, anxiety, depression)
Number of subjects: 0
Study 32189446 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based training (SBT)
Number of subjects: 47
Study 32189446 — intervention group
Group type: COMPARATOR
Intervention: Non-simulation-based training (NSBT)
Number of subjects: 47
Study 35972259 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniMed 780G advanced hybrid closed loop (AHCL) system
Number of subjects: 41
Study 35972259 — intervention group
Group type: COMPARATOR
Intervention: MDI+BGM
Number of subjects: 41
Study 35065636 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg of curcuminoid + 5 mg piperine)
Number of subjects: 76
Study 35065636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32029142 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteromorpha powder (3% supplementation)
Number of subjects: 312
Study 32029142 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 312
Study 36370716 — intervention group
Group type: COMPARATOR
Intervention: q3EC-P (epirubicin 90 mg/m2 and cyclophosphamide 600 mg/m2 every 3 weeks followed by paclitaxel 175 mg/m2 every 3 weeks)
Number of subjects: 2091
Study 36370716 — intervention group
Group type: COMPARATOR
Intervention: q3FEC-P (fluorouracil 600 mg/m2, epirubicin 90 mg/m2, and cyclophosphamide 600 mg/m2 every 3 weeks followed by paclitaxel 175 mg/m2 every 3 weeks)
Number of subjects: 2091
Study 36370716 — intervention group
Group type: EXPERIMENTAL
Intervention: q2EC-P (epirubicin 90 mg/m2 and cyclophosphamide 600 mg/m2 every 2 weeks followed by paclitaxel 175 mg/m2 every 2 weeks)
Number of subjects: 2091
Study 36370716 — intervention group
Group type: EXPERIMENTAL
Intervention: q2FEC-P (fluorouracil 600 mg/m2, epirubicin 90 mg/m2, and cyclophosphamide 600 mg/m2 every 2 weeks followed by paclitaxel 175 mg/m2 every 2 weeks)
Number of subjects: 2091
Study 36083316 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide
Number of subjects: 0
Study 36083316 — intervention group
Group type: EXPERIMENTAL
Intervention: Darolutamide
Number of subjects: 0
Study 36083316 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 0
Study 36083316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36083316 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of Apalutamide, Darolutamide, and Enzalutamide
Number of subjects: 0
Study 32556496 — intervention group
Group type: EXPERIMENTAL
Intervention: Literature-mining approach analyzing cancer immunotherapy publications
Number of subjects: 93033
Study 32556496 — intervention group
Group type: EXPERIMENTAL
Intervention: Research topics in cancer immunotherapy
Number of subjects: 93033
Study 32556496 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical research transition
Number of subjects: 93033
Study 35512165 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm sling with kinesiotaping therapy (group K)
Number of subjects: 40
Study 35512165 — intervention group
Group type: COMPARATOR
Intervention: Arm sling only (group S)
Number of subjects: 40
Study 35512165 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 34814193 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand sanitizer group (HSG)
Number of subjects: 911
Study 34814193 — intervention group
Group type: EXPERIMENTAL
Intervention: Soap-and-water group (SWG)
Number of subjects: 911
Study 34814193 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 911
Study 36073634 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 238
Study 33434049 — intervention group
Group type: EXPERIMENTAL
Intervention: Readmitted cases
Number of subjects: 50
Study 33434049 — intervention group
Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 50
Study 35886615 — intervention group
Group type: EXPERIMENTAL
Intervention: Noom Weight program
Number of subjects: 50
Study 35886615 — intervention group
Group type: COMPARATOR
Intervention: Weekly educational newsletters (Control)
Number of subjects: 50
Study 34776149 — intervention group
Group type: COMPARATOR
Intervention: PBM in knee extensor + plantar-flexor (KE + FP_G)
Number of subjects: 60
Study 34776149 — intervention group
Group type: COMPARATOR
Intervention: PBM in plantar-flexor (PF_G)
Number of subjects: 60
Study 34776149 — intervention group
Group type: COMPARATOR
Intervention: Control (CG)
Number of subjects: 60
Study 34776149 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SG)
Number of subjects: 60
Study 34776149 — intervention group
Group type: COMPARATOR
Intervention: PBM in knee extensor (KE_G)
Number of subjects: 60
Study 35321452 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal group (combined examination of Doppler, contrast, and elastography)
Number of subjects: 100
Study 35321452 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐RCNN segmentation algorithm
Number of subjects: 100